Neuroimmunology: An expanding frontier in autoimmunity

Frontiers in Immunology

Volumn 6, Issue APR, 2015, Pages

  Höftberger, Romana ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anti neuronal antibodies; Anti NMDAR encephalitis; Autoimmune encephalitis; Limbic encephalitis; Tissue based assay

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANTIGEN; AUTOANTIBODY; CXCL13 CHEMOKINE; MEMBRANE PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SYNAPTIC PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALITIS; ARTICLE; AUTOIMMUNITY; CEREBROSPINAL FLUID; DEMENTIA; DEMYELINATING DISEASE; HERPES SIMPLEX ENCEPHALITIS; HUMAN; IMMUNE RESPONSE; MENTAL DISEASE; NERVE CELL; NERVE DEGENERATION; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; VIRUS ENCEPHALITIS;

EID: 84934285262     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00206     Document Type: Article

References (15)

1. Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci (2015) 1338(1):94-114. doi: 10.1111/nyas.12553
2. Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol (2014) 13:167-77. doi:10.1016/S1474-4422(13)70282-5
3. Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol (2013) 12:157-65. doi:10.1016/S1474-4422(12)70310-1
4. Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol (2014) 10:579-96. doi:10.1038/nrneurol.2014.148
5. Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol (2009) 65:424-34. doi:10.1002/ana.21589
6. Ohkawa T, Fukata Y, Yamasaki M, Milyazaki T, Yokoi N, Takashima H, et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci (2013) 33:18161-74. doi:10.1523/JNEUROSCI.3506-13.2013
7. Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol (2010) 9:67-76. doi:10.1016/S1474-4422(09)70324-2
8. Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, et al. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol (2013) 73:120-8. doi:10.1002/ana.23756
9. Balint B, Jarius S, Nagel S, Haberkorn U, Probst C, Blocker IM, et al. Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology (2014) 82:1521-8. doi:10.1212/WNL.0000000000000372
10. Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol (2014) 13:575-86. doi:10.1016/S1474-4422(14)70051-1
11. Armangue T, Santamaria J, Dalmau J. When a serum test overrides the clinical assessment. Neurology (2015) 84:1379-81. doi:10.1212/WNL.0000000000001425
12. Zandi MS, Paterson RW, Ellul MA, Jacobson L, Al-Diwani A, Jones JL, et al. Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes. J Neurol Neurosurg Psychiatry (2014). doi:10.1136/jnnp-2014-308736
13. Armangue T, Leypoldt F, Malaga I, Raspall-Chaure M, Marti I, Nichter C, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol (2014) 75:317-23. doi:10.1002/ana.24083
14. Leypoldt F, Hoftberger R, Titulaer MJ, Armangue T, Gresa-Arribas N, Jahn H, et al. Investigations on CXCL13 in anti-N-methyl-d-aspartate receptor encephalitis: a potential biomarker of treatment response. JAMA Neurol (2015) 72:180-6. doi:10.1001/jamaneurol.2014.2956
15. Titulaer MJ, Hoftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, et al. Overlapping demyelinating syndromes and anti-N-methyl-d-aspartate receptor encephalitis. Ann Neurol (2014) 75:411-28. doi:10.1002/ana.24117